Compare PTGX & POR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | POR |
|---|---|---|
| Founded | 2006 | 1889 |
| Country | United States | United States |
| Employees | N/A | 2915 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.6B |
| IPO Year | 2016 | 1994 |
| Metric | PTGX | POR |
|---|---|---|
| Price | $92.39 | $53.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 11 |
| Target Price | ★ $100.17 | $48.09 |
| AVG Volume (30 Days) | 489.3K | ★ 1.5M |
| Earning Date | 06-01-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.77 |
| Revenue | N/A | ★ $3,576,000,000.00 |
| Revenue This Year | $711.26 | $6.68 |
| Revenue Next Year | N/A | $5.56 |
| P/E Ratio | ★ N/A | $19.31 |
| Revenue Growth | N/A | ★ 3.95 |
| 52 Week Low | $39.60 | $39.55 |
| 52 Week High | $96.54 | $54.39 |
| Indicator | PTGX | POR |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 59.41 |
| Support Level | $76.63 | $47.25 |
| Resistance Level | $92.05 | $54.39 |
| Average True Range (ATR) | 3.87 | 0.98 |
| MACD | 0.79 | -0.04 |
| Stochastic Oscillator | 80.77 | 74.80 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two-thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.5 gigawatts of gas, coal, wind, and hydro generation along with 300 megawatts of energy storage.